2021, Vol. 3, Issue 1, Part G

Background: Adverse Drug Reactions (ADRs) are a public health issue that health providers need to address. Health practitioners play a significant part in improving the healthcare environment, which is a cornerstone of the pharmacovigilance programme.

Objective: To evaluate the awareness of pharmacovigilance expertise and practice among doctors in our college.

Methods: A questionnaire with 15 pharmacovigilance questions has been created. Convenient and purposive sampling techniques were used, which contacted and invited doctors at our institute to engage in this research. This required participants to be recruited who were willing to provide pharmacovigilance information at our hospital.

Results: It was found that doctors had excellent knowledge of the basic principles for pharmacovigilance in 20%, good in 38%, average in 14% and poor in 28%. 28% of people had low pharmacovigilance awareness, 7% of whom had no practical knowledge of pharmacovigilance, and had zero results in class A. The response was outstanding for 26 percent, good for 26 percent, average for 16 percent and poor for 32 percent. Out of 32 percent of respondents with inadequate expertise, 20 percent were unable to provide any productive advice or viewpoint on the pharmacovigilance improvement scheme and scored zero in Class D.

Conclusion: This research concluded that awareness and practice on various aspects of pharmacovigilance among residents was increased after proper sensitization. Better perception may also eliminate misunderstandings, obstacles and barriers to a better healthcare system' s use of pharmacovigilance.